Filing Flows › Stereotaxis (STXS) › R&D spending
Stereotaxis (STXS) R&D spending by quarter
Stereotaxis' R&D spending was $2.4M in Q2 2026 (second quarter 2026), -0.3% from Q1 2026. Over the last 6 quarters it ranged from $2.4M (Q1 2025) to $2.8M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $2.4M | -0.3% | — |
| Q1 2026 | $2.4M | -12% | +2% |
| Q4 2025 | $2.7M | +6% | -3% |
| Q3 2025 | $2.5M | +8% | — |
| Q1 2025 | $2.4M | -16% | — |
| Q4 2024 | $2.8M | — | — |
Q2 2026 at a glance
Stereotaxis, Q2 2026: revenue $7.7M (-13% year over year), operating margin -59.6%, net loss $4.5M, operating cash flow −$3.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Stereotaxis' R&D spending?
Stereotaxis' R&D spending was $2.4M in Q2 2026 (second quarter 2026), -0.3% from Q1 2026.
How has Stereotaxis' R&D spending changed?
Over the last 6 quarters it ranged from $2.4M (Q1 2025) to $2.8M (Q4 2024).